231 related articles for article (PubMed ID: 30035749)
1. TNF overproduction impairs epithelial staphylococcal response in hyper IgE syndrome.
Myles IA; Anderson ED; Earland NJ; Zarember KA; Sastalla I; Williams KW; Gough P; Moore IN; Ganesan S; Fowler CJ; Laurence A; Garofalo M; Kuhns DB; Kieh MD; Saleem A; Welch PA; Darnell DA; Gallin JI; Freeman AF; Holland SM; Datta SK
J Clin Invest; 2018 Aug; 128(8):3595-3604. PubMed ID: 30035749
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Role of
Moffitt K; Cheung E; Manis J; Malley R
Infect Immun; 2018 May; 86(5):. PubMed ID: 29463618
[TBL] [Abstract][Full Text] [Related]
3. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome.
Milner JD; Brenchley JM; Laurence A; Freeman AF; Hill BJ; Elias KM; Kanno Y; Spalding C; Elloumi HZ; Paulson ML; Davis J; Hsu A; Asher AI; O'Shea J; Holland SM; Paul WE; Douek DC
Nature; 2008 Apr; 452(7188):773-6. PubMed ID: 18337720
[TBL] [Abstract][Full Text] [Related]
4. The Potential and Limits of Hematopoietic Stem Cell Transplantation for the Treatment of Autosomal Dominant Hyper-IgE Syndrome.
Yanagimachi M; Ohya T; Yokosuka T; Kajiwara R; Tanaka F; Goto H; Takashima T; Morio T; Yokota S
J Clin Immunol; 2016 Jul; 36(5):511-6. PubMed ID: 27091139
[TBL] [Abstract][Full Text] [Related]
5. SH2-domain mutations in STAT3 in hyper-IgE syndrome patients result in impairment of IL-10 function.
Giacomelli M; Tamassia N; Moratto D; Bertolini P; Ricci G; Bertulli C; Plebani A; Cassatella M; Bazzoni F; Badolato R
Eur J Immunol; 2011 Oct; 41(10):3075-84. PubMed ID: 21792878
[TBL] [Abstract][Full Text] [Related]
6. Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome.
Minegishi Y; Saito M; Nagasawa M; Takada H; Hara T; Tsuchiya S; Agematsu K; Yamada M; Kawamura N; Ariga T; Tsuge I; Karasuyama H
J Exp Med; 2009 Jun; 206(6):1291-301. PubMed ID: 19487419
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3.
Ma CS; Chew GY; Simpson N; Priyadarshi A; Wong M; Grimbacher B; Fulcher DA; Tangye SG; Cook MC
J Exp Med; 2008 Jul; 205(7):1551-7. PubMed ID: 18591410
[TBL] [Abstract][Full Text] [Related]
8. Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation.
Siegel AM; Stone KD; Cruse G; Lawrence MG; Olivera A; Jung MY; Barber JS; Freeman AF; Holland SM; O'Brien M; Jones N; Nelson CG; Wisch LB; Kong HH; Desai A; Farber O; Gilfillan AM; Rivera J; Milner JD
J Allergy Clin Immunol; 2013 Dec; 132(6):1388-96. PubMed ID: 24184145
[TBL] [Abstract][Full Text] [Related]
9.
Park B; Liu GY
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33271763
[TBL] [Abstract][Full Text] [Related]
10. Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome.
Al Khatib S; Keles S; Garcia-Lloret M; Karakoc-Aydiner E; Reisli I; Artac H; Camcioglu Y; Cokugras H; Somer A; Kutukculer N; Yilmaz M; Ikinciogullari A; Yegin O; Yüksek M; Genel F; Kucukosmanoglu E; Baki A; Bahceciler NN; Rambhatla A; Nickerson DW; McGhee S; Barlan IB; Chatila T
J Allergy Clin Immunol; 2009 Aug; 124(2):342-8, 348.e1-5. PubMed ID: 19577286
[TBL] [Abstract][Full Text] [Related]
11. STAT3 mutation-associated airway epithelial defects in Job syndrome.
Zhang Y; Lin T; Leung HM; Zhang C; Wilson-Mifsud B; Feldman MB; Puel A; Lanternier F; Couderc LJ; Danion F; Catherinot E; Salvator H; Tcherkian C; Givel C; Xu J; Tearney GJ; Vyas JM; Li H; Hurley BP; Mou H
J Allergy Clin Immunol; 2023 Aug; 152(2):538-550. PubMed ID: 36638921
[TBL] [Abstract][Full Text] [Related]
12. Successful haploidentical donor hematopoietic stem cell transplant and restoration of STAT3 function in an adolescent with autosomal dominant hyper-IgE syndrome.
Patel NC; Gallagher JL; Torgerson TR; Gilman AL
J Clin Immunol; 2015 Jul; 35(5):479-85. PubMed ID: 25962528
[TBL] [Abstract][Full Text] [Related]
13. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.
Boos AC; Hagl B; Schlesinger A; Halm BE; Ballenberger N; Pinarci M; Heinz V; Kreilinger D; Spielberger BD; Schimke-Marques LF; Sawalle-Belohradsky J; Belohradsky BH; Przybilla B; Schaub B; Wollenberg A; Renner ED
Allergy; 2014 Jul; 69(7):943-53. PubMed ID: 24898675
[TBL] [Abstract][Full Text] [Related]
14. Th2 and Th9 responses in patients with chronic mucocutaneous candidiasis and hyper-IgE syndrome.
Becker KL; Rösler B; Wang X; Lachmandas E; Kamsteeg M; Jacobs CW; Joosten LA; Netea MG; van de Veerdonk FL
Clin Exp Allergy; 2016 Dec; 46(12):1564-1574. PubMed ID: 27474157
[TBL] [Abstract][Full Text] [Related]
15. Quantitative defects in invariant NKT cells and TLR responses in patients with hyper-IgE syndrome.
Gutierrez-Hincapié S; Muskus-López CE; Montoya CJ; Trujillo-Vargas CM
Allergol Immunopathol (Madr); 2015; 43(6):553-61. PubMed ID: 25796310
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of hyper IgE syndrome.
Heimall J; Freeman A; Holland SM
Clin Rev Allergy Immunol; 2010 Feb; 38(1):32-8. PubMed ID: 19452285
[TBL] [Abstract][Full Text] [Related]
17. [Hyper-IgE syndrome with mutation in STAT3 gene - case report and literature review].
Heropolitańska-Pliszka E; Pietrucha B; Mikołuć B; Bernatowska E
Med Wieku Rozwoj; 2009; 13(1):19-25. PubMed ID: 19648655
[TBL] [Abstract][Full Text] [Related]
18. Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes.
Freeman AF; Holland SM
Pediatr Res; 2009 May; 65(5 Pt 2):32R-37R. PubMed ID: 19190525
[TBL] [Abstract][Full Text] [Related]
19. Expansion of T helper type 17 lymphocytes in patients with chronic granulomatous disease.
Horváth R; Rožková D; Lašťovička J; Poloučková A; Sedláček P; Sedivá A; Spíšek R
Clin Exp Immunol; 2011 Oct; 166(1):26-33. PubMed ID: 21910722
[TBL] [Abstract][Full Text] [Related]
20. Hyper-IgE syndrome update.
Sowerwine KJ; Holland SM; Freeman AF
Ann N Y Acad Sci; 2012 Feb; 1250():25-32. PubMed ID: 22268731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]